Clinical Trials in Dallas

Showing 2841-2860 of 15,003 trials

Heat Waves and the Elderly - Cooling Modalities

NCT05484739

The purpose of this study is to assess how well cooling modalities work in reducing cardiovascular stress of the elderly to heat wave conditions

AgingHyperthermia

University of Texas Southwestern Medical Center100 participantsStarted Feb 2023

Dallas, Texas, United States

Active Not RecruitingPhase 3< 1 mile

A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

NCT04825743

This is a Phase 3 prospective, blinded, randomized, placebo controlled, international multicenter study. Subjects with STEMI will be enrolled in the ambulance if they meet all eligibility criteria. These subjects will be evaluated by (para)medics who transport the subjects to the participating hospitals in Europe and North America. Hospitals and ambulance services with experience in ambulance studies will be selected. Each subject will receive a single subcutaneous injection containing either Disaggpro(tm) zalunfiban Dose 1 (0.110 mg/kg) or Disaggpro(tm) zalunfiban Dose 2 (0.130 mg/kg) or placebo

ST-elevation Myocardial Infarction (STEMI)

CeleCor Therapeutics2,463 participantsStarted Apr 2021

Anchorage, Alaska, United States • Royal Oak, Michigan, United States • St Louis, Missouri, United States +42 more locations

Heat Waves and the Elderly - Cooling Modalities

A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Find Trials by Condition in Dallas

Cardiovascular Responses to Heat Waves in the Elderly

Minima Stent System Post- Approval Study (PAS)

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

Word Learning From Parentese in Autistic Children

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)